KR840009035A - 피부 침투 치료 시스템용 매트릭스 조성물 - Google Patents

피부 침투 치료 시스템용 매트릭스 조성물 Download PDF

Info

Publication number
KR840009035A
KR840009035A KR1019840002320A KR840002320A KR840009035A KR 840009035 A KR840009035 A KR 840009035A KR 1019840002320 A KR1019840002320 A KR 1019840002320A KR 840002320 A KR840002320 A KR 840002320A KR 840009035 A KR840009035 A KR 840009035A
Authority
KR
South Korea
Prior art keywords
composition
mineral oil
drug
clonidine
polyisobutylene
Prior art date
Application number
KR1019840002320A
Other languages
English (en)
Other versions
KR890000650B1 (ko
Inventor
제이. 엔스코어(외 1) 데이비드
Original Assignee
에드워드 엘. 맨델
알자 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에드워드 엘. 맨델, 알자 코포레이션 filed Critical 에드워드 엘. 맨델
Publication of KR840009035A publication Critical patent/KR840009035A/ko
Application granted granted Critical
Publication of KR890000650B1 publication Critical patent/KR890000650B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/08—Mineral waters; Sea water
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Abstract

내용 없음

Description

피부 침투 치료 시스템용 매트릭스 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 적층형으로 된 피부 침투치료 시스템의 개략적인 단면도.
제2도는 MO-PIB겔의 CSD함량과 클로니딘 및 스코폴아민 조성의 접도간의 관계를 나타낸 그래프.
제3도는 MO/PIB와 시험관내에서의 클로니딘 유리율간의 관계를 나타낸 그래프.

Claims (15)

  1. MO/PIB비가 적어도 1.0이고 적어도 1.5×107포이즈의 접도를 가짐을 특징으로 하는 광물질오일, 폴리이소부틸렌 및 적어도 5%의 콜로이드성 이산화실리콘으로 구성된 약제전달 시스템내의 매트릭스로서 사용하기가 적당한 조성물.
  2. 청구범위 제1항에 있어서, 광물질오일에 가용성인 분산될 약제를 40%까지 포함하는 바의 조성물.
  3. 청구범위 제2항에 있어서, 상기 약제가 조성물내에 약제의 포화농도와 약 20% 사이의 준위로 존재하는 바의 조성물.
  4. 청구범위 제3항에 있어서, 광물오일 대 폴리이소부틸렌의 비가 적어도 1.2이고, 조성물이 적어도 7.5 중량%의 콜로이드성 이산화실리콘을 포함하는 바의 조성물.
  5. 청구범위 제4항에 있어서의 상기 약제가 클로니딘, 스코폴리아민, 프로프탄올올, 에스트라디올, 페닐프로판올아민, 오우아바인, 살부탐올, 과나벤즈, 라베폴올, 아트로핀, 할로페리돌, 브로모크리프린, 클로로페니라민, 메트리포네이트, 이소소트비드 디나이트레이트 및 니트로글레세린으로 구성된 그룹으로부터 선택한 바의 조성물.
  6. 청구범위 제1항에 있어서, 상기 약제가 클로니딘이고 클로니딘에 대한 조성물의 침투력이 적어도 1.0×10-4㎍/cm sec인 바의 조성물.
  7. 청구범위 제6항에 있어서 MO/PIB의 값이 적어도 1.2인 바의 조성물.
  8. 적당한 광물질오일에 가용성인 약제가 상기층 내에 상기 약제의 포화농도 이상의 농도로 상기 저장층 내에 분산된 약제 저장층, 접착층 및 상기 저장층과 접착층 사이에 배치된 약제 유리속도 조절막으로 구성되었으며 상기 저장층과 상기 접착층은 광물질오일과 폴리이소부틸렌의 혼합물을 포함하는 시스템에서 저장 및 접착층이 적어도 5%의 콜로이드성 이산화실리콘을 포함하고 적어도 1.5×107포이즈의 접도를 갖고 저장 및 접착층내 광물질오일 대 폴리이소부틸렌의 비가 적어도 1:2로 개량됨을 특징으로 하는 피부침투 재료 시스템.
  9. 청구범위 제8항에 있어서, 상기 유리속도 조절막이 광물질 오일을 포함하고 피부침투 치료시스템내 MO/PIB의 전체 비율이 적어도 1.4인 바의 피부침투 치료 시스템.
  10. 청구범위 제9항에 있어서, 상기 약제를 클로니딘, 스코폴아민, 프로프탄올올, 에스트라디올, 페닐프로판올아민, 오우아바인, 살부람올, 과나벤즈, 타베톨올, 아트로픽, 할로페리돌, 브로모크리프린, 칼로로페니타민, 메르티포네이트, 이소소트비드디나이트레이트 및 니트로글레세린으로부터 선택한 바의 피부침투 치료시스템.
  11. 청구범위 제9항에 있어서, 상기 약제가 클로니딘이고 시스템으로부터 환부로의 시험관적 약제 유리속도는 적어도 2.0㎍/㎠hr인 바의 시스템.
  12. 분산시키고자 하는 광물질오일에 가용성인 약제를 함유한 광물질오일과 폴리이소부틸렌의 겔로 구성물에서 이 조성물이 분산될 5%의 콜로이드성 이산화실리콘을 갖고, MO/PIB비가 적어도 1.0이며 접도가 1.5×107포이즈로 계량된 약제 함유 메트릭스 조성물.
  13. 청구범위 제11항에 있어서, 상기 MO/PIB비가 적어도 1.2이고, 콜로이드성 이산화실리콘이 6-10%의 양으로 존재하며, 상기 약제가 포화농도 이하의 양 및 40%보다 많지 않은 양으로 존재하는 바의 메트릭스 조성물.
  14. 청구범위 제12항에 있어서, 상기 약제가 클로니딘이고 클로니딘에 대한 매트릭스의 침투력이 적어도 1×10-4㎍/cm sec인 바의 조성물.
  15. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840002320A 1983-05-04 1984-04-30 피부 침투투약 기구용 매트릭스 조성물 및 그 기구 KR890000650B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US491,490 1983-05-04
US491490 1983-05-04
US06/491,490 US4559222A (en) 1983-05-04 1983-05-04 Matrix composition for transdermal therapeutic system

Publications (2)

Publication Number Publication Date
KR840009035A true KR840009035A (ko) 1984-12-24
KR890000650B1 KR890000650B1 (ko) 1989-03-22

Family

ID=23952451

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840002320A KR890000650B1 (ko) 1983-05-04 1984-04-30 피부 침투투약 기구용 매트릭스 조성물 및 그 기구

Country Status (15)

Country Link
US (1) US4559222A (ko)
JP (1) JPS59206307A (ko)
KR (1) KR890000650B1 (ko)
AU (1) AU558304B2 (ko)
BE (1) BE899444A (ko)
CA (1) CA1217139A (ko)
CH (1) CH666190A5 (ko)
DE (1) DE3416248C2 (ko)
ES (1) ES8600943A1 (ko)
FR (1) FR2545357B1 (ko)
GB (1) GB2140019B (ko)
IT (1) IT1179635B (ko)
NL (1) NL190508C (ko)
SE (1) SE463012B (ko)
ZA (1) ZA843037B (ko)

Families Citing this family (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
EP0156080B2 (en) * 1984-03-05 1993-10-20 Nitto Denko Corporation Percutaneous absorption type adhesive pharmaceutical preparation
DE3409079A1 (de) * 1984-03-13 1985-09-19 Bayer Ag, 5090 Leverkusen Medizinische pflaster
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US5008111A (en) * 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
DE3518707A1 (de) * 1985-05-24 1986-11-27 Beiersdorf Ag, 2000 Hamburg Nitro-pflaster
AU610839B2 (en) * 1986-11-07 1991-05-30 Purepac, Inc Transdermal administration of amines
US5171576A (en) * 1987-03-09 1992-12-15 Alza Corporation Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5118509A (en) * 1987-03-09 1992-06-02 Alza Corporation Inducing skin tolerance to a sensitizing drug
US5077054A (en) * 1987-03-09 1991-12-31 Alza Corporation Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5000956A (en) * 1987-03-09 1991-03-19 Alza Corporation Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
US5049387A (en) * 1987-03-09 1991-09-17 Alza Corporation Inducing skin tolerance to a sensitizing drug
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
WO1990006120A1 (en) * 1988-12-01 1990-06-14 Schering Corporation Compositions for transdermal delivery of estradiol
US4973468A (en) * 1989-03-22 1990-11-27 Cygnus Research Corporation Skin permeation enhancer compositions
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5053227A (en) * 1989-03-22 1991-10-01 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5130139A (en) * 1990-07-06 1992-07-14 Alza Corporation Reduction or prevention of skin irritation by drugs
US5160741A (en) * 1990-07-06 1992-11-03 Alza Corporation Reduction or prevention of skin irritation by drugs
US5149539A (en) * 1990-08-03 1992-09-22 Alza Corporation Reduction or prevention of sensitization to drugs
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
IT1251469B (it) * 1991-07-15 1995-05-15 Zambon Spa Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante.
US5273755A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
US5234690A (en) * 1991-08-23 1993-08-10 Cygnus Therapeutic Systems Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
CA2116036A1 (en) * 1991-10-18 1993-04-29 F. Eugene Yates Device for the transdermal administration of melatonin
AU666735B2 (en) * 1992-05-13 1996-02-22 Alza Corporation Transdermal administration of oxybutynin
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
US5451407A (en) * 1993-06-21 1995-09-19 Alza Corporation Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
EP0705097B2 (en) * 1993-06-25 2004-01-14 Alza Corporation Incorporating poly-n-vinyl amide in a transdermal system
GB2281036A (en) * 1993-08-02 1995-02-22 Agri Tech Topical compositions containing polybutenes
EP0721348B1 (en) * 1993-09-29 1999-09-01 Alza Corporation Monoglyceride/lactate ester permeation enhancer
WO1996022083A1 (en) * 1995-01-19 1996-07-25 Cygnus, Inc. POLYISOBUTYLENE ADHESIVES CONTAINING HIGH Tg TACKIFIER FOR TRANSDERMAL DEVICES
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US6572879B1 (en) 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
US6512010B1 (en) * 1996-07-15 2003-01-28 Alza Corporation Formulations for the administration of fluoxetine
DK0934078T3 (da) * 1996-10-24 2003-04-14 Alza Corp Permeabilitetsfremmere til transdermal administrering af aktivstoffer, anordninger og fremgangsmåde til fremstilling deraf
DE19654468C1 (de) * 1996-12-27 1998-01-22 Lohmann Therapie Syst Lts Extrem flexibles, dermal oder transdermal wirkendes Pflaster und Verfahren zu seiner Herstellung
US6203817B1 (en) 1997-02-19 2001-03-20 Alza Corporation Reduction of skin reactions caused by transdermal drug delivery
GB9711032D0 (en) * 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
AU756136B2 (en) 1997-06-23 2003-01-02 Queen's University At Kingston Microdose therapy
US5948433A (en) * 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US6660295B2 (en) 1997-09-30 2003-12-09 Alza Corporation Transdermal drug delivery device package with improved drug stability
US6267984B1 (en) 1997-12-22 2001-07-31 Alza Corporation Skin permeation enhancer compositions comprising a monoglyceride and ethyl palmitate
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
US6699497B1 (en) 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
US6348210B1 (en) 1998-11-13 2002-02-19 Alza Corporation Methods for transdermal drug administration
CN101693023A (zh) 1998-12-18 2010-04-14 阿尔扎有限公司 透明的透皮烟碱输送装置
ES2395057T3 (es) 1999-03-25 2013-02-07 Metabolix, Inc. Dispositivos y aplicaciones médicas de polímeros polihidroxialcanoato
US6616942B1 (en) * 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
WO2000059483A2 (en) * 1999-04-01 2000-10-12 Alza Corporation Transdermal drug delivery devices comprising a polyurethane drug reservoir
CA2382599C (en) 1999-08-30 2005-11-08 Tepha, Inc. Flushable disposable polymeric products
EP1103260B1 (de) * 1999-11-29 2005-01-26 Novosis AG Transdermalsystem zur Abgabe von Clonidin
US6602912B2 (en) * 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
DE10003767A1 (de) 2000-01-28 2001-10-04 Beiersdorf Ag Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung nichtsteroidaler Antirheumatika
AT414205B (de) * 2000-06-20 2006-10-15 Vis Vitalis Lizenz & Handels Verfahren zur herstellung von ungesättigtem fettsäure-trockenkonzentrat
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
US7691404B2 (en) * 2000-11-06 2010-04-06 Samyang Corporation Transdermal delivery system of diclofenac with improved water absorbability and adhesion properties
KR20100036390A (ko) 2001-03-06 2010-04-07 셀러지 파마세우티칼스, 인크 비뇨생식기 장애 치료용 화합물 및 그 방법
US7588786B2 (en) * 2001-11-14 2009-09-15 Jarrow Formulas, Inc. Eutectic-based self-nanoemulsified drug delivery system
AT410633B (de) * 2002-04-25 2003-06-25 Oekopharm Forschungs Und Entwi Verwendung eines auf einer biologisch inerten, hochdispersen matrix getrockneten stutenmilchkonzentrats
IL152575A (en) * 2002-10-31 2008-12-29 Transpharma Medical Ltd A skin-to-skin transmission system of water-insoluble drugs
IL152573A (en) * 2002-10-31 2009-11-18 Transpharma Medical Ltd A system for the transmission through the skin of a medical preparation against vomiting and nausea
US20040258742A1 (en) * 2003-04-11 2004-12-23 Van Osdol William Woodson Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
US20040208917A1 (en) * 2003-04-16 2004-10-21 Wilfried Fischer Transdermal systems for the release of clonidine
ES2527857T3 (es) 2003-05-08 2015-01-30 Tepha, Inc. Tejidos y fibras médicas de polihidroxialcanoato
US20040237400A1 (en) * 2003-05-27 2004-12-02 Weder Donald E. Plant package with floral wrapper with decorative portion
EP1682102A2 (en) * 2003-09-10 2006-07-26 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
EP1670325A1 (en) 2003-09-29 2006-06-21 Soft Gel Technologies, Inc. SOLUBILIZED CoQ-10
UA84303C2 (ru) * 2003-10-28 2008-10-10 Новен Фармасьютикалз, Инк. Система для трансдермальной доставки лечебного средства
DE10357321A1 (de) * 2003-12-05 2005-07-21 Tesa Ag Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
TWI239252B (en) * 2003-12-31 2005-09-11 Ind Tech Res Inst A patch and the manufacturing method of the same
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
ATE556727T1 (de) 2004-08-03 2012-05-15 Tepha Inc Polyhydroxyalkanoate nähte die sich nicht aufrollen
US20060078602A1 (en) 2004-10-08 2006-04-13 Noven Pharmaceuticals, Inc. Device for transdermal administration of drugs including acrylic polymers
ES2596809T3 (es) 2004-10-08 2017-01-12 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos que incluye un refuerzo oclusivo
US8343538B2 (en) * 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
TW200616589A (en) * 2004-10-08 2006-06-01 Noven Pharma Transdermal delivery of drugs based on crystal size
ATE551995T1 (de) 2004-10-21 2012-04-15 Durect Corp Transdermale abgabesysteme
US8252320B2 (en) 2004-10-21 2012-08-28 Durect Corporation Transdermal delivery system for sufentanil
US7888422B2 (en) 2005-11-09 2011-02-15 Mylan Technologies Inc. Long-wearing removable pressure sensitive adhesive
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
WO2007121188A2 (en) * 2006-04-10 2007-10-25 Knopp Neurosciences, Inc. Compositions and methods of using r(+) pramipexole
PL2026803T3 (pl) 2006-05-16 2012-05-31 Knopp Neurosciences Inc Kompozycje R(+) i S(-) pramipeksolu i sposoby ich zastosowania
US20100184848A1 (en) * 2006-07-14 2010-07-22 William Abraham Wine Transdermal formulations of synthetic cannabinoids and nano colloidal silica
PT2117521E (pt) 2006-11-03 2012-09-10 Durect Corp Sistemas de administração transdérmica que compreendem bupivacaína
CN101190183B (zh) * 2006-11-29 2010-05-12 上海医药工业研究院 一种盐酸可乐定多泡脂质体及其制备方法
US7943683B2 (en) 2006-12-01 2011-05-17 Tepha, Inc. Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
RU2454409C2 (ru) 2007-03-14 2012-06-27 Нопп Ньюросайенсиз, Инк. Синтез хирально очищенных замещенных бензотиазолдиаминов
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
US9017301B2 (en) * 2007-09-04 2015-04-28 Mylan Technologies, Inc. Transdermal drug delivery systems comprising a coated release liner
EP2111857A1 (de) * 2008-04-25 2009-10-28 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
KR20110071064A (ko) 2008-08-19 2011-06-28 크놉 뉴로사이언시스 인코포레이티드 (ｒ)-프라미펙솔을 사용하는 조성물 및 방법
US20110009460A1 (en) * 2009-06-19 2011-01-13 Valentin Gribkoff Compositions and methods for treating amyotrophic lateral sclerosis
EP2456839A1 (en) * 2009-07-21 2012-05-30 Mylan Inc. Process for the continuous manufacture of a polyisobutylene based transdermal patch
EP2295046B1 (de) * 2009-09-14 2012-12-19 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
CN103313710A (zh) * 2010-11-02 2013-09-18 积水医疗株式会社 贴剂
US9114258B2 (en) 2011-01-04 2015-08-25 Kato Medical Systems Llc Electrokinetic nerve stimulator
CN103732611B (zh) 2011-01-10 2016-06-01 伊沃恩有限公司 β-肾上腺素能反向激动剂用于戒烟的用途
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
CN103893155B (zh) * 2012-12-26 2018-11-06 江苏康倍得药业股份有限公司 一种药物透皮贴剂
US9072682B2 (en) * 2012-12-31 2015-07-07 Mylan Inc. Transdermal dosage form for low-melting point active agent
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
WO2014188329A2 (en) 2013-05-20 2014-11-27 Mylan, Inc. Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
SI3019167T1 (sl) 2013-07-12 2021-04-30 Knopp Biosciences Llc Zdravljenje povišanih ravni eozinofilcev in / ali bazofilcev
WO2015023786A1 (en) 2013-08-13 2015-02-19 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
US9763918B2 (en) 2013-08-13 2017-09-19 Knopp Biosciences Llc Compositions and methods for treating chronic urticaria
US10500303B2 (en) 2014-08-15 2019-12-10 Tepha, Inc. Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
CA2962080A1 (en) 2014-09-24 2016-03-31 Pain Therapeutics, Inc. 4:3 naltrexone: 5-methyl-2-furaldehyde cocrystal
US10626521B2 (en) 2014-12-11 2020-04-21 Tepha, Inc. Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
WO2016094669A1 (en) 2014-12-11 2016-06-16 Tepha, Inc. Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
US11096936B2 (en) 2015-09-24 2021-08-24 Cassava Sciences, Inc. Cocrystals of naloxone and naltrexone
JP2020510086A (ja) 2017-03-24 2020-04-02 イー インク カリフォルニア， エルエルシー 活性分子を送達するためのマイクロセルシステム
TWI670089B (zh) 2017-03-24 2019-09-01 美商伊英克加利福尼亞有限責任公司 用於調節活性物投送速率之包含帶電或磁性粒子的微胞遞送系統
JP6972334B2 (ja) 2017-11-14 2021-11-24 イー インク カリフォルニア， エルエルシー 多孔性伝導電極層を含む電気泳動活性分子送達システム
US11938214B2 (en) 2019-11-27 2024-03-26 E Ink Corporation Benefit agent delivery system comprising microcells having an electrically eroding sealing layer
EP4236927A1 (en) 2020-10-29 2023-09-06 E Ink California, LLC Microcell systems for delivering hydrophilic active molecules
CN116322881A (zh) 2020-10-29 2023-06-23 伊英克加利福尼亚有限责任公司 用于递送有益剂的微单元系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2627938A (en) * 1948-08-10 1953-02-10 Res Prod Corp Method of making high viscosity products having petroleum oil base and product of such method
US2628205A (en) * 1950-10-21 1953-02-10 Res Prod Corp Viscous hydrophilic composition and method of making the same
US2775561A (en) * 1952-07-02 1956-12-25 Res Prod Corp Viscous composition and method of making the same
US3029188A (en) * 1958-02-20 1962-04-10 Olin Mathieson Gelatin adhesive pharmaceutical preparations
US3079299A (en) * 1959-11-16 1963-02-26 Gen Aerosol Corp Self-propelling medicinal ointment composition containing polyethylene and method ofapplication
CA758049A (en) * 1960-07-19 1967-05-02 The Gillette Company Heat-generating cosmetic composition
GB1050858A (ko) * 1963-06-07
US3215599A (en) * 1963-07-02 1965-11-02 Warner Lambert Pharmaceutical Process for preparing polymer waxmodified petroleum oil unctuous base
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
US3574827A (en) * 1966-12-29 1971-04-13 Exxon Research Engineering Co Ointment base composition
US3733403A (en) * 1970-01-26 1973-05-15 Squibb & Sons Inc Gelled mineral oil
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
FR2435950A1 (fr) * 1978-06-05 1980-04-11 Riker Laboratories Inc Pansement medical comprenant une composition a base de nitroglycerine, sa fabrication et son application
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4314557A (en) * 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
US4725272A (en) * 1981-06-29 1988-02-16 Alza Corporation Novel bandage for administering beneficial drug

Also Published As

Publication number Publication date
NL190508B (nl) 1993-11-01
JPS59206307A (ja) 1984-11-22
NL190508C (nl) 1994-04-05
SE8402389D0 (sv) 1984-05-03
FR2545357B1 (fr) 1987-10-23
IT8467445A1 (it) 1985-11-03
US4559222A (en) 1985-12-17
KR890000650B1 (ko) 1989-03-22
ES532228A0 (es) 1985-10-16
CA1217139A (en) 1987-01-27
ZA843037B (en) 1984-11-28
NL8401262A (nl) 1984-12-03
DE3416248A1 (de) 1984-11-08
SE463012B (sv) 1990-10-01
JPH0460091B2 (ko) 1992-09-25
CH666190A5 (de) 1988-07-15
IT8467445A0 (it) 1984-05-03
ES8600943A1 (es) 1985-10-16
GB8407741D0 (en) 1984-05-02
AU558304B2 (en) 1987-01-22
IT1179635B (it) 1987-09-16
AU2717184A (en) 1984-11-08
GB2140019B (en) 1986-09-17
FR2545357A1 (fr) 1984-11-09
BE899444A (fr) 1984-08-16
SE8402389L (sv) 1984-11-05
GB2140019A (en) 1984-11-21
DE3416248C2 (de) 1993-10-28

Similar Documents

Publication Publication Date Title
KR840009035A (ko) 피부 침투 치료 시스템용 매트릭스 조성물
ATE184473T1 (de) Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
US4588580A (en) Transdermal administration of fentanyl and device therefor
FI112171B (fi) Menetelmä transdermaalisiin välineisiin soveltuvien polyisobutyleeniliimojen valmistamiseksi
JP3916664B2 (ja) グリセロールモノラウレートとラウリルアセテートとを含む皮膚透過増強剤組成物
EP0259136B1 (en) Transdermal delivery device having a rate controlling adhesive
AU594908B2 (en) Transdermal contraceptive formulations
KR900004330A (ko) 약물/침투 증대제 조성물과 관련된 피부자극의 감소방법
CA2264687C (en) Permeation enhancers for transdermal drug delivery compositions, devices, and methods
DE3205258C2 (ko)
US4904247A (en) Pressure-sensitive hydrophilic laminate structures for use in wound dressing, transdermal and topical drug delivery
US5641504A (en) Skin permeation enhancer compositions using glycerol monolinoleate
KR880012216A (ko) 활성성분 배합물용 경피성 치료계
KR920700602A (ko) 폐경기후의 증후군을 치료하기 위한 경피 흡수 투여 단위 및 투여 방법
ATE152630T1 (de) Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
KR890004688A (ko) 생활성 물질의 조절성 방출성을 위한 피복 제재
KR950031038A (ko) 폴리비닐피롤리돈과 키토산 유도체의 상호반응에 의해 형성된 겔
BR9509897A (pt) Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal
JPS61158924A (ja) ナロキソン，ナルトレキソン又はナルブフインの投与のための経皮治療系
KR910007508A (ko) 서방출 드레싱용 제제 및 이의 용도
KR900700128A (ko) 외상 치료법
ATE108680T1 (de) Therapeutisches system zur verzögerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii).
KR850004389A (ko) 경피침투가 증진된 생리학적 활성제제의 제조방법
ATE253820T1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
KR970705381A (ko) 흡수성 첨가제를 함유하는 에스트라디올 트랜스더멀 치료 시스템

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030317

Year of fee payment: 15

EXPY Expiration of term